Science Market Update
As people get older, their bodies become more susceptible to certain diseases. Cancer, among others, is a disease that becomes more common as people age. David S. Yu, M.D., Ph.D from Emory University was recently awarded $1.6 million from the National Institutes of Health (NIH) to study the gene SIRT2 and how it can be manipulated to control the effects of aging and prevent cancer.Read More
Cancer affects the majority of the population in one way or another, through knowing someone with cancer, being exposed to it in the media, or having it oneself. Cancer treatments and cures are some of the most well funded and highly researched areas in the life sciences. Researchers at the Winshop Cancer Institute at Emory University in Atlanta, GA recently discovered that an orange pigment, called parietin or physcion, that is found in lichens and rhubarb has potential to be used as an anti-cancer drug.Read More
Since the Human Immunodeficiany Virus (HIV) emerged as a global health problem, researchers have been diligently working to discover new vaccines to treat the disease. However, many of the current treatments for HIV tend to cause more infections and further damage instead of working as a cure.Read More
When the level of blood glucose, also called blood sugar, rises after a meal, the pancreas responds by releasing insulin into the bloodstream. Insulin helps cells throughout the body absorb glucose from the bloodstream and use it for energy.Read More
The University of Georgia in Athens and Emory University in Atlanta are two powerhouse research institutions, both receiving millions of dollars in annual funding to support research projects. Not only are researchers at these 2 universities hard at work on their own projects, but researchers from both institutions are also hard at work on collaborative projects between the schools.Read More
Alzheimer's is a devastating disease that causes memory loss, thinking and behavioral problems that get worse over time. Currently, there are no known cures for Alzheimer's, but there are some treatments available that can slow the onset of symptoms. Because of this need for a cure, Alzheimer's disease is heavily studied by researchers across the nation, and millions of dollars are given to Alzheimer's researchers annually to work towards finding more treatments and a potential cure. Earlier this year, researchers at Emory University in Atlanta, Georgia received a $7.2 million, five-year grant from the National Institutes of Health (NIH) to help support their research of this disease. (Image on right courtesy of Wikimedia Commons)Read More
Fragile X syndrome is a neurodegenerative, genetic disease that causes intellectual, behavioral, and learning challenges. According to the CDC, it is the most common cause of inherited intellectual disability and even though it affects both men and women, it occurs more commonly and more severely in men. There are many other diseases associated with Fragile X, such as autism and epilepsy. Currently, there are no cures for the syndrome, but there are treatments that can help people suffering from the disorder learn some important skills. Emory University researchers have recently received a $9 million grant from the National Institutes of Health to continue their study of Fragile X syndrome and its associated disorders.Read More
If you're a researcher in Atlanta, you have the opportunity to meet other researchers and learn about the latest life science solutions on the market by attending Biotechnology Calendar, Inc.’s Emory University life science marketing event. Our Atlanta BioResearch Product Faire™ Event will be held on February 27th, 2014. Last year, our Atlanta BioResearch Product Faire™ Event attracted 213 attendees. This year, make sure you don't miss out on our popular Emory event where hundreds of your colleagues will enjoy one another's company, a free catered lunch and door prizes.
Researchers at Emory University have discovered a way of packaging stem cells that make them much more effective in heart therapies. Using a capsule made of alginate, a gel-like substance, the researchers package the stem cells and attach them to the heart within a patch. According to Emory University, this capsule cause the stem cells’ healing to take place over time, rather than dying soon after they are introduced to the body, as they do without the capsule.